Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease.

Gershon AS, Chung H, Porter J, Campitelli MA, Buchan SA, Schwartz KL, Crowcroft NS, Campigotto A, Gubbay JB, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson DC, Richardson SE, Rosella LC, Simor AE, Smieja M, Zahariadis G, Kwong JC.

J Infect Dis. 2019 Sep 24. pii: jiz419. doi: 10.1093/infdis/jiz419. [Epub ahead of print]

PMID:
31549165
2.

Evaluating the use of whole genome sequencing for the investigation of a large mumps outbreak in Ontario, Canada.

Stapleton PJ, Eshaghi A, Seo CY, Wilson S, Harris T, Deeks SL, Bolotin S, Goneau LW, Gubbay JB, Patel SN.

Sci Rep. 2019 Aug 30;9(1):12615. doi: 10.1038/s41598-019-47740-1.

3.

Influenza Vaccine Effectiveness Among Patients With Cancer: A Population-Based Study Using Health Administrative and Laboratory Testing Data From Ontario, Canada.

Blanchette PS, Chung H, Pritchard KI, Earle CC, Campitelli MA, Buchan SA, Schwartz KL, Crowcroft NS, Gubbay JB, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson DC, Richardson SE, Rosella LC, Simor A, Smieja M, Zahariadis G, Campigotto A, Kwong JC.

J Clin Oncol. 2019 Oct 20;37(30):2795-2804. doi: 10.1200/JCO.19.00354. Epub 2019 Aug 29.

PMID:
31465264
4.

Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort.

Kwong JC, Buchan SA, Chung H, Campitelli MA, Schwartz KL, Crowcroft NS, Jackson ML, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson DC, Richardson SE, Rosella LC, Simor A, Smieja M, Zahariadis G, Campigotto A, Gubbay JB.

Vaccine. 2019 Jul 18;37(31):4392-4400. doi: 10.1016/j.vaccine.2019.06.011. Epub 2019 Jun 17.

5.

Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) study.

Bolotin S, Severini A, Hatchette T, McLachlan E, Savage R, Hughes SL, Wang J, Deeks SL, Wilson S, Brisson M, Halperin SA, Gubbay J, Mazzulli T, Serhir B, Ward BJ, Crowcroft N.

Hum Vaccin Immunother. 2019 Jul 16:1-9. doi: 10.1080/21645515.2019.1619402. [Epub ahead of print]

PMID:
31184979
6.

Influenza virus RNA recovered from droplets and droplet nuclei emitted by adults in an acute care setting.

Yip L, Finn M, Granados A, Prost K, McGeer A, Gubbay JB, Scott J, Mubareka S.

J Occup Environ Hyg. 2019 May;16(5):341-348. doi: 10.1080/15459624.2019.1591626. Epub 2019 May 3.

PMID:
31050610
7.

Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ‎possible cohort effect following the 2009 influenza pandemic.

Skowronski DM, Leir S, De Serres G, Murti M, Dickinson JA, Winter AL, Olsha R, Croxen MA, Drews SJ, Charest H, Martineau C, Sabaiduc S, Bastien N, Li Y, Petric M, Jassem A, Krajden M, Gubbay JB.

Euro Surveill. 2019 Apr;24(15). doi: 10.2807/1560-7917.ES.2019.24.15.1900104.

8.

Cost-effectiveness of measles control during elimination in Ontario, Canada, 2015.

Ramsay LC, Crowcroft NS, Thomas S, Aruffo E, Teslya A, Heffernan JM, Gournis E, Hiebert J, Jaeger V, Jiaravuthisan M, Sharron J, Severini A, Deeks SL, Gubbay J, Mazzulli T, Sander B.

Euro Surveill. 2019 Mar;24(11). doi: 10.2807/1560-7917.ES.2019.24.11.1800370.

9.

Characteristics and Outcomes of Young Children Hospitalized With Laboratory-confirmed Influenza or Respiratory Syncytial Virus in Ontario, Canada, 2009-2014.

Buchan SA, Chung H, Karnauchow T, McNally JD, Campitelli MA, Gubbay JB, Katz K, McGeer AJ, Richardson DC, Richardson SE, Simor A, Smieja M, Zahariadis G, Tran D, Crowcroft NS, Rosella LC, Kwong JC.

Pediatr Infect Dis J. 2019 Apr;38(4):362-369. doi: 10.1097/INF.0000000000002164.

PMID:
30882725
10.

Equity and impact: Ontario's infant rotavirus immunization program five years following implementation. A population-based cohort study.

Wilson SE, Rosella LC, Wang J, Renaud A, Le Saux N, Crowcroft NS, Desai S, Harris T, Bolotin S, Gubbay J, Deeks SL.

Vaccine. 2019 Apr 17;37(17):2408-2414. doi: 10.1016/j.vaccine.2019.01.061. Epub 2019 Feb 11.

11.

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019.

Skowronski DM, Leir S, Sabaiduc S, Murti M, Dickinson JA, Olsha R, Gubbay JB, Croxen MA, Charest H, Chan T, Bastien N, Li Y, Krajden M, De Serres G.

Euro Surveill. 2019 Jan;24(4). doi: 10.2807/1560-7917.ES.2019.24.4.1900055.

12.

Effects of Absolute Humidity, Relative Humidity, Temperature, and Wind Speed on Influenza Activity in Toronto, Ontario, Canada.

Peci A, Winter AL, Li Y, Gnaneshan S, Liu J, Mubareka S, Gubbay JB.

Appl Environ Microbiol. 2019 Mar 6;85(6). pii: e02426-18. doi: 10.1128/AEM.02426-18. Print 2019 Mar 15.

13.

Genetic characterization of human metapneumovirus identified through community and facility-based surveillance of infants in Dhaka, Bangladesh.

Rahman MZ, Sumiya M, Sahabuddin M, Pell LG, Gubbay JB, Rahman R, Momtaz F, Azmuda N, Shanta SS, Jahan I, Rahman M, Mahmud AA, Roth DE, Morris SK.

J Med Virol. 2019 Apr;91(4):549-554. doi: 10.1002/jmv.25351. Epub 2018 Nov 13.

PMID:
30372530
14.

Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010-2011 to 2017-2018.

Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Drews SJ, Fonseca K, Charest H, Martineau C, Hickman R, Chan T, Jassem A, Petric M, Rose C, Bastien N, Li Y, Krajden M.

Clin Infect Dis. 2019 May 2;68(10):1754-1757. doi: 10.1093/cid/ciy876.

15.

Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?

Chambers C, Skowronski DM, Rose C, Serres G, Winter AL, Dickinson JA, Jassem A, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Petric M, Krajden M.

Open Forum Infect Dis. 2018 Sep 4;5(9):ofy211. doi: 10.1093/ofid/ofy211. eCollection 2018 Sep.

16.

Targeting Intracellular Ion Homeostasis for the Control of Respiratory Syncytial Virus.

Norris MJ, Malhi M, Duan W, Ouyang H, Granados A, Cen Y, Tseng YC, Gubbay J, Maynes J, Moraes TJ.

Am J Respir Cell Mol Biol. 2018 Dec;59(6):733-744. doi: 10.1165/rcmb.2017-0345OC.

PMID:
30095982
17.

Zoonotic Influenza and Human Health-Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies.

Mehta K, Goneau LW, Wong J, L'Huillier AG, Gubbay JB.

Curr Infect Dis Rep. 2018 Aug 1;20(10):38. doi: 10.1007/s11908-018-0643-8. Review.

PMID:
30069787
18.

Zoonotic Influenza and Human Health-Part 1: Virology and Epidemiology of Zoonotic Influenzas.

Goneau LW, Mehta K, Wong J, L'Huillier AG, Gubbay JB.

Curr Infect Dis Rep. 2018 Aug 1;20(10):37. doi: 10.1007/s11908-018-0642-9. Review.

PMID:
30069735
19.

Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.

Golden AR, Adam HJ, Karlowsky JA, Baxter M, Nichol KA, Martin I, Demczuk W, Van Caeseele P, Gubbay JB, Lefebvre B, Levett PN, Zahariadis G, Haldane D, Gad R, German G, Gilmour MW, Mulvey MR, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance (CARA).

J Antimicrob Chemother. 2018 Jul 1;73(suppl_7):vii20-vii31. doi: 10.1093/jac/dky157.

PMID:
29982573
20.

Limitations of administrative data to identify measles cases in Ontario, Canada: a cautionary tale.

Johnson C, Chen C, Rosella L, Rilkoff H, Marchand-Austin A, Gubbay JB, Kozlowski T, Deeks SL, Mazzulli T, Crowcroft N.

Can J Public Health. 2018 Feb;109(1):3-7. doi: 10.17269/s41997-018-0021-1. Epub 2018 Feb 26.

PMID:
29981059
21.

Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.

Demczuk WHB, Martin I, Desai S, Griffith A, Caron-Poulin L, Lefebvre B, McGeer A, Tyrrell GJ, Zhanel GG, Gubbay J, Hoang L, Levett PN, Van Caeseele P, Raafat Gad R, Haldane D, Zahariadis G, German G, Daley Bernier J, Strudwick L, Mulvey MR.

Vaccine. 2018 Jul 25;36(31):4701-4707. doi: 10.1016/j.vaccine.2018.06.018. Epub 2018 Jun 21.

PMID:
29937245
22.

Laboratory testing and phylogenetic analysis during a mumps outbreak in Ontario, Canada.

L'Huillier AG, Eshaghi A, Racey CS, Ogbulafor K, Lombos E, Higgins RR, Alexander DC, Kristjanson E, Maregmen J, Gubbay JB, Mazzulli T.

Virol J. 2018 Jun 5;15(1):98. doi: 10.1186/s12985-018-0996-5.

23.

Canada-Wide Epidemic of emm74 Group A Streptococcus Invasive Disease.

Teatero S, McGeer A, Tyrrell GJ, Hoang L, Smadi H, Domingo MC, Levett PN, Finkelstein M, Dewar K, Plevneshi A, Athey TBT, Gubbay JB, Mulvey MR, Martin I, Demczuk W, Fittipaldi N.

Open Forum Infect Dis. 2018 Apr 20;5(5):ofy085. doi: 10.1093/ofid/ofy085. eCollection 2018 May.

24.

Zika virus infection in a pregnant Canadian traveler with congenital fetal malformations noted by ultrasonography at 14-weeks gestation.

Schwartz KL, Chan T, Rai N, Murphy KE, Whittle W, Drebot MA, Gubbay J, Boggild AK.

Trop Dis Travel Med Vaccines. 2018 Apr 4;4:2. doi: 10.1186/s40794-018-0062-8. eCollection 2018.

25.

Rotavirus genotypes circulating in Ontario, Canada, before and after implementation of the rotavirus immunization program.

Isabel S, Higgins RR, Peci A, Isabel MR, Deeks SL, Gubbay JB.

Vaccine. 2018 Apr 5;36(15):2033-2040. doi: 10.1016/j.vaccine.2018.02.064. Epub 2018 Mar 8.

PMID:
29526372
26.

Seasonal Influenza Forecasting in Real Time Using the Incidence Decay With Exponential Adjustment Model.

Nasserie T, Tuite AR, Whitmore L, Hatchette T, Drews SJ, Peci A, Kwong JC, Friedman D, Garber G, Gubbay J, Fisman DN.

Open Forum Infect Dis. 2017 Sep 27;4(3):ofx166. doi: 10.1093/ofid/ofx166. eCollection 2017 Summer.

27.

Use of Genome Sequencing to Define Institutional Influenza Outbreaks, Toronto, Ontario, Canada, 2014-15.

MacFadden DR, McGeer A, Athey T, Perusini S, Olsha R, Li A, Eshaghi A, Gubbay JB, Hanage WP.

Emerg Infect Dis. 2018 Mar;24(3):492-497. doi: 10.3201/eid2403.171499.

28.

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.

Skowronski DM, Chambers C, De Serres G, Dickinson JA, Winter AL, Hickman R, Chan T, Jassem AN, Drews SJ, Charest H, Gubbay JB, Bastien N, Li Y, Krajden M.

Euro Surveill. 2018 Feb;23(5). doi: 10.2807/1560-7917.ES.2018.23.5.18-00035. Erratum in: Euro Surveill. 2018 Jul;23(30):.

29.

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis G, Gubbay JB.

N Engl J Med. 2018 Jan 25;378(4):345-353. doi: 10.1056/NEJMoa1702090.

30.

Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada.

Buchan SA, Chung H, Campitelli MA, Crowcroft NS, Gubbay JB, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson D, Richardson SE, Rosella LC, Simor A, Smieja M, Tran D, Zahariadis G, Kwong JC.

PLoS One. 2017 Nov 17;12(11):e0187834. doi: 10.1371/journal.pone.0187834. eCollection 2017.

31.

Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay JB, Drews SJ, Martineau C, Charest H, Krajden M, Bastien N, Li Y.

J Infect Dis. 2017 Dec 19;216(12):1487-1500. doi: 10.1093/infdis/jix526.

32.

Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada.

Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Krajden M, Petric M, Bastien N, Li Y.

J Infect Dis. 2017 Sep 15;216(6):697-702. doi: 10.1093/infdis/jix393.

33.

The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009-2014.

Bolotin S, Lim G, Dang V, Crowcroft N, Gubbay J, Mazzulli T, Schabas R.

PLoS One. 2017 Aug 29;12(8):e0181172. doi: 10.1371/journal.pone.0181172. eCollection 2017.

34.

Lineage-specific epitope profiles for HPAI H5 pre-pandemic vaccine selection and evaluation.

Qiu X, Duvvuri VR, Gubbay JB, Webby RJ, Kayali G, Bahl J.

Influenza Other Respir Viruses. 2017 Sep;11(5):445-456. doi: 10.1111/irv.12466. Epub 2017 Aug 12.

35.

Measles Outbreak with Unique Virus Genotyping, Ontario, Canada, 2015.

Thomas S, Hiebert J, Gubbay JB, Gournis E, Sharron J, Severini A, Jiaravuthisan M, Shane A, Jaeger V, Crowcroft NS, Fediurek J, Sander B, Mazzulli T, Schulz H, Deeks SL.

Emerg Infect Dis. 2017 Jul;23(7):1063-1069. doi: 10.3201/eid2307.161145.

36.

Epidemiology of Zika virus, 1947-2007.

Posen HJ, Keystone JS, Gubbay JB, Morris SK.

BMJ Glob Health. 2016 Aug 1;1(2):e000087. doi: 10.1136/bmjgh-2016-000087. eCollection 2016.

37.

Measuring influenza RNA quantity after prolonged storage or multiple freeze/thaw cycles.

Granados A, Petrich A, McGeer A, Gubbay JB.

J Virol Methods. 2017 Sep;247:45-50. doi: 10.1016/j.jviromet.2017.05.018. Epub 2017 May 29.

PMID:
28572040
38.

Evaluation of Euroimmun Anti-Zika Virus IgM and IgG Enzyme-Linked Immunosorbent Assays for Zika Virus Serologic Testing.

L'Huillier AG, Hamid-Allie A, Kristjanson E, Papageorgiou L, Hung S, Wong CF, Stein DR, Olsha R, Goneau LW, Dimitrova K, Drebot M, Safronetz D, Gubbay JB.

J Clin Microbiol. 2017 Aug;55(8):2462-2471. doi: 10.1128/JCM.00442-17. Epub 2017 May 31.

39.

Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing.

Demczuk WHB, Martin I, Hoang L, Van Caeseele P, Lefebvre B, Horsman G, Haldane D, Gubbay J, Ratnam S, German G, Daley Bernier J, Strudwick L, McGeer A, Zhanel GG, Van Domselaar G, Graham M, Mulvey MR.

PLoS One. 2017 May 22;12(5):e0178040. doi: 10.1371/journal.pone.0178040. eCollection 2017.

40.

Global Distribution and Evolutionary History of Enterovirus D68, with Emphasis on the 2014 Outbreak in Ontario, Canada.

Eshaghi A, Duvvuri VR, Isabel S, Banh P, Li A, Peci A, Patel SN, Gubbay JB.

Front Microbiol. 2017 Mar 1;8:257. doi: 10.3389/fmicb.2017.00257. eCollection 2017.

41.

Evaluation of Altona Diagnostics RealStar Zika Virus Reverse Transcription-PCR Test Kit for Zika Virus PCR Testing.

L'Huillier AG, Lombos E, Tang E, Perusini S, Eshaghi A, Nagra S, Frantz C, Olsha R, Kristjanson E, Dimitrova K, Safronetz D, Drebot M, Gubbay JB.

J Clin Microbiol. 2017 May;55(5):1576-1584. doi: 10.1128/JCM.02153-16. Epub 2017 Mar 15.

42.

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.

Skowronski DM, Chambers C, Sabaiduc S, Dickinson JA, Winter AL, De Serres G, Drews SJ, Jassem A, Gubbay JB, Charest H, Balshaw R, Bastien N, Li Y, Krajden M.

Euro Surveill. 2017 Feb 9;22(6). pii: 30460. doi: 10.2807/1560-7917.ES.2017.22.6.30460.

43.

Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.

Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Krajden M, Petric M, Bastien N, Li Y, Smith DJ.

J Infect Dis. 2017 Apr 1;215(7):1059-1099. doi: 10.1093/infdis/jix074.

44.

Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05-2013/14, Toronto, Canada.

Coleman BL, Hassan K, Green K, Gubbay JB, Katz K, Mazzulli T, McNeil S, Muller M, Powis J, Richardson D, Simor A; TIBDN, McGeer AJ.

Antiviral Res. 2017 Apr;140:158-163. doi: 10.1016/j.antiviral.2017.01.025. Epub 2017 Feb 6.

PMID:
28179155
45.

Whole-genome Sequencing for Surveillance of Invasive Pneumococcal Diseases in Ontario, Canada: Rapid Prediction of Genotype, Antibiotic Resistance and Characterization of Emerging Serotype 22F.

Deng X, Memari N, Teatero S, Athey T, Isabel M, Mazzulli T, Fittipaldi N, Gubbay JB.

Front Microbiol. 2016 Dec 27;7:2099. doi: 10.3389/fmicb.2016.02099. eCollection 2016.

46.

Challenges in Interpretation of Diagnostic Test Results in a Mumps Outbreak in a Highly Vaccinated Population.

Trotz-Williams LA, Mercer NJ, Paphitis K, Walters JM, Wallace D, Kristjanson E, Gubbay J, Mazzulli T.

Clin Vaccine Immunol. 2017 Feb 6;24(2). pii: e00542-16. doi: 10.1128/CVI.00542-16. Print 2017 Feb.

47.

Detecting and quantifying influenza virus with self- versus investigator-collected mid-turbinate nasal swabs.

Granados A, Quach S, McGeer A, Gubbay JB, Kwong JC.

J Med Virol. 2017 Jul;89(7):1295-1299. doi: 10.1002/jmv.24753. Epub 2017 Feb 27.

PMID:
27943313
48.

Influenza and rhinovirus viral load and disease severity in upper respiratory tract infections.

Granados A, Peci A, McGeer A, Gubbay JB.

J Clin Virol. 2017 Jan;86:14-19. doi: 10.1016/j.jcv.2016.11.008. Epub 2016 Nov 22.

PMID:
27893998
49.

Maternal vitamin D supplementation during pregnancy and lactation to prevent acute respiratory infections in infancy in Dhaka, Bangladesh (MDARI trial): protocol for a prospective cohort study nested within a randomized controlled trial.

Morris SK, Pell LG, Rahman MZ, Dimitris MC, Mahmud A, Islam MM, Ahmed T, Pullenayegum E, Kashem T, Shanta SS, Gubbay J, Papp E, Science M, Zlotkin S, Roth DE.

BMC Pregnancy Childbirth. 2016 Oct 13;16(1):309.

50.

The epidemiology of invasive pneumococcal disease in older adults from 2007 to 2014 in Ontario, Canada: a population-based study.

Desai S, Policarpio ME, Wong K, Gubbay J, Fediurek J, Deeks S.

CMAJ Open. 2016 Sep 29;4(3):E545-E550. eCollection 2016 Jul-Sep.

Supplemental Content

Loading ...
Support Center